SCHEMBL2070313

SCHEMBL2070313

Cn1nnnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4405816 0.67
SCHEMBL75716 0.67
SCHEMBL4407825 0.65
SCHEMBL10616300 0.65
SCHEMBL10874941 0.65 SMN1; SMN2 (0.41)
SCHEMBL4408869 0.65 ALDH1A1 (0.39)
SCHEMBL1107488 0.65
SCHEMBL2985000 0.65
SCHEMBL94304 0.65
SCHEMBL1543317 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11535575-B2 Lead-free initiating agents or initiating agent mixtures DYNITEC GMBH (DE) 2022-12-27 US claimed
EP-3481792-B1 LEAD-FREE INITIATING AGENTS OR INITIATING AGENT MIXTURES DYNITEC GMBH (DE) 2022-09-28 EP claimed
US-20190256438-A1 LEAD-FREE INITIATING AGENTS OR INITIATING AGENT MIXTURES DYNITEC GMBH (DE) 2019-08-22 US claimed
EP-3481792-A1 LEAD-FREE INITIATING AGENTS OR INITIATING AGENT MIXTURES Dynitec GmbH (DE) 2019-05-15 EP claimed
US-10224485-B2 Process for preparing a crystalline organic semiconductor material BASF SE (DE) 2019-03-05 US claimed
US-20170012208-A1 ORGANIC SEMICONDUCTOR FORMULATIONS USINVEST LLC 2017-01-12 US claimed
US-20240254143-A1 OREXIN RECEPTOR AGONISTS AND USES THEREOF APTUIT (VERONA) SRL (IT) 2024-08-01 US disclosed
CN-117616030-A Orexin receptor agonists and uses thereof 爵士制药爱尔兰有限公司 2024-02-27 CN disclosed
EP-3183250-B1 PROCESS FOR PREPARING CRYSTALLINE ORGANIC SEMICONDUCTOR MATERIAL CLAP CO LTD (KR) 2023-10-04 EP disclosed
US-11535575-B2 Lead-free initiating agents or initiating agent mixtures DYNITEC GMBH (DE) 2022-12-27 US disclosed
EP-3481792-B1 LEAD-FREE INITIATING AGENTS OR INITIATING AGENT MIXTURES DYNITEC GMBH (DE) 2022-09-28 EP disclosed
EP-3183757-B1 ORGANIC SEMICONDUCTOR COMPOSITION COMPRISING LIQUID MEDIUM CLAP CO LTD (KR) 2022-05-04 EP disclosed
CN-107004768-B Organic semiconductor composition containing a liquid medium 巴斯夫欧洲公司 2020-08-21 CN disclosed
US-20080146569-A1 Nicotinamide Derivatives PFIZER INC. 2008-06-19 US disclosed
US-20080076924-A1 Piperazines as P2X7 antagonists ABBOTT LABORATORIES 2008-03-27 US disclosed
EP-1859782-A1 Composition for coloring and/or lightening human hair comprising tetrazoles Henkel Kommanditgesellschaft auf Aktien (DE) 2007-11-28 EP disclosed
CN-1562984-A Compound of hydrosulfuryl-substitution azacycle UNIV ZHEJIANG POLYTECHNIC (CN) 2005-01-12 CN disclosed
EP-0035228-B1 TETRAZOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND ANTI-ULCER COMPOSITION CONTAINING THE SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1985-01-02 EP disclosed
US-4372953-A Tetrazole derivatives, and anti-ulcer composition containing the same OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1983-02-08 US disclosed
EP-0035228-A1 Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1981-09-09 EP disclosed